UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

Journal of bone and mineral research, 2011-05, Vol.26 (5), p.1012-1021

2011

Volltextzugriff (PDF)

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2647-2656

2010

Volltextzugriff (PDF)

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL

Journal of bone and mineral research, 2009-02, Vol.24 (2), p.182-195

2009

Volltextzugriff (PDF)

Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody

Endocrinology (Philadelphia), 2014-12, Vol.155 (12), p.4785-4797

2014

Volltextzugriff (PDF)

Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats

Endocrinology (Philadelphia), 2011-09, Vol.152 (9), p.3312-3322

2011

Volltextzugriff (PDF)

Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene

Bone (New York, N.Y.), 2011-12, Vol.49 (6), p.1178-1185

2011

Volltextzugriff (PDF)

RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

Journal of bone and mineral research, 2008-05, Vol.23 (5), p.672-682

2008

Volltextzugriff (PDF)

One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength

Journal of bone and mineral research, 2009-07, Vol.24 (7), p.1234-1246

2009

Volltextzugriff (PDF)

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

Nature reviews. Drug discovery, 2012-05, Vol.11 (5), p.401-419

2012

Volltextzugriff (PDF)

Osteoclast differentiation and activation

Nature (London), 2003-05, Vol.423 (6937), p.337-342

2003

Volltextzugriff (PDF)

Freedom of assembly: metabolic enzymes come together

Molecular biology of the cell, 2020-06, Vol.31 (12), p.1201-1205

2020

Volltextzugriff (PDF)

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Genes & development, 1998-05, Vol.12 (9), p.1260-1268

1998

Volltextzugriff (PDF)

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Bone (New York, N.Y.), 2006-10, Vol.39 (4), p.754-766

2006

Volltextzugriff (PDF)

Influence of humans on evolution and mobilization of environmental antibiotic resistome

Emerging infectious diseases, 2013-07, Vol.19 (7)

2013

Volltextzugriff (PDF)

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

The Journal of experimental medicine, 2000-08, Vol.192 (4), p.463-474

2000

Volltextzugriff (PDF)

What is REDD+ achieving on the ground?

Current opinion in environmental sustainability, 2018-06, Vol.32, p.134-140

2018

Volltextzugriff (PDF)

REDD+ in Theory and Practice: How Lessons From Local Projects Can Inform Jurisdictional Approaches

Frontiers in Forests and Global Change, 2020-02, Vol.3

2020

Volltextzugriff (PDF)

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Genes & development, 1998-05, Vol.12 (9), p.1260-1268

1998

Volltextzugriff (PDF)

Dickkopf‐1 regulates bone formation in young growing rodents and upon traumatic injury

Journal of bone and mineral research, 2011-11, Vol.26 (11), p.2610-2621

2011

Volltextzugriff (PDF)

Leading Process Branch Instability in Lis1+/− Nonradially Migrating Interneurons

Cerebral cortex (New York, N.Y. 1991), 2010-06, Vol.20 (6), p.1497-1505

2010

Volltextzugriff (PDF)

Inhibition of WISE Preserves Renal Allograft Function

Journal of the American Society of Nephrology, 2013-01, Vol.24 (1), p.66-76

2013

Volltextzugriff (PDF)

Genomic discovery of osteoprotegerin and development of inhibitors of RANKL

Bone (New York, N.Y.), 2008-10, Vol.43, p.S17-S17

Simonet, William Scott

2008

Volltextzugriff (PDF)

Birth outcomes and infant mortality among First Nations Inuit, and non-Indigenous women by northern versus southern residence, Quebec

Journal of epidemiology and community health (1979), 2012-04, Vol.66 (4), p.328-333

2012

Volltextzugriff (PDF)

Leading Process Branch Instability in Lis1 super(+)/-Nonradially Migrating Interneurons

Cerebral cortex (New York, N.Y. 1991), 2010-01, Vol.20 (6), p.1497-1505

2010

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(32)
Humans
(22)
Biological And Medical Sciences
(19)
Animals
(18)
Male
(16)
Female
(14)
Fundamental And Applied Biological Sciences. Psychology
(11)
Medical Sciences
(11)
Endocrinology & Metabolism
(10)
Adult
(8)
Rats
(8)
Mice
(7)
Orthopedics
(7)
Osteoprotegerin
(7)
Rats, Sprague-Dawley
(7)
Vertebrates: Osteoarticular System, Musculoskeletal System
(7)
Skeleton And Joints
(6)
Antibodies, Monoclonal - Pharmacology
(5)
Bone Density - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock‐In Mice That Express Chimeric (Murine/Human) RANKL

Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody

Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats

Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene

RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength

Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab

Osteoclast differentiation and activation

Freedom of assembly: metabolic enzymes come together

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Critical knowledge gaps and research needs related to the environmental dimensions of antibiotic resistance

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

Influence of humans on evolution and mobilization of environmental antibiotic resistome

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

What is REDD+ achieving on the ground?

REDD+ in Theory and Practice: How Lessons From Local Projects Can Inform Jurisdictional Approaches

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Dickkopf‐1 regulates bone formation in young growing rodents and upon traumatic injury

Leading Process Branch Instability in Lis1+/− Nonradially Migrating Interneurons

Inhibition of WISE Preserves Renal Allograft Function

Genomic discovery of osteoprotegerin and development of inhibitors of RANKL

Birth outcomes and infant mortality among First Nations Inuit, and non-Indigenous women by northern versus southern residence, Quebec

Leading Process Branch Instability in Lis1 super(+)/-Nonradially Migrating Interneurons

Suchergebnisse filtern